Most just lately, it has been identified that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to your wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions for a scavenger and isn't going to activate